Contraception News and Research RSS Feed - Contraception News and Research

Lilly, Merck expand oncology clinical trial collaboration

Lilly, Merck expand oncology clinical trial collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced the extension of an existing collaboration to evaluate the safety and efficacy of the combination of Lilly's ALIMTA (pemetrexed for injection) and Merck's KEYTRUDA (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC). [More]
Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation). [More]
Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns

Researchers examine risk of four common types of ovarian cancer in women with different childbearing patterns

The more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 National Cancer Research Institute Cancer Conference today (Tuesday). [More]
Impact of physicians' unconscious attitudes toward disabled and LGBT patients

Impact of physicians' unconscious attitudes toward disabled and LGBT patients

Physicians' unconscious attitudes toward special patient populations like disabled and LGBT patients may be partially responsible for poorer overall health observed in these communities, according to a Rowan University professor of family medicine. [More]
Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Osteopathic physicians, researchers and aligned medical professionals will present clinical and research updates in 15 specialties at OMED 15 in Orlando October 17-21. [More]
Research shows more than 30,000 women die from cardiovascular disease in UK

Research shows more than 30,000 women die from cardiovascular disease in UK

More than 30,000 women die from coronary heart disease in the UK every year with over 700,000 women living with the consequences of heart disease and stroke, according to research published by The British Heart Foundation ahead of World Heart Day on 29th September. [More]
Johns Hopkins study highlights need for effective postpartum interventions for women with pregnancy complications

Johns Hopkins study highlights need for effective postpartum interventions for women with pregnancy complications

Citing an analysis of more than 26,000 Maryland Medicaid claims, Johns Hopkins researchers report evidence that poor women with recent complications during their pregnancies are using the emergency room at higher rates after delivery and may not be getting the postpartum care and follow-up they need to prevent further health problems. [More]
FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy. [More]
Report: Birth control pills cause significant increase in stroke risk

Report: Birth control pills cause significant increase in stroke risk

Birth control pills cause a small but significant increase in the risk of the most common type of stroke, according to a comprehensive report in the journal MedLink Neurology. [More]
Pregnant teenagers at higher risk of more pregnancies in teenage years

Pregnant teenagers at higher risk of more pregnancies in teenage years

Nearly a quarter of teenagers in England and Wales who have had an abortion have been pregnant before, according to new research from the University of East Anglia. [More]
Researchers discover new strategy for attacking cancer cells

Researchers discover new strategy for attacking cancer cells

University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease. [More]
UVA researchers identify new strategy for attacking cancer cells

UVA researchers identify new strategy for attacking cancer cells

University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease. By more selectively targeting cancer cells, this method offers a strategy to reduce the length of and physical toll associated with current treatments. [More]
Comprehensive review looks at safety, efficacy of treatment options for premenstrual dysphoric disorder

Comprehensive review looks at safety, efficacy of treatment options for premenstrual dysphoric disorder

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome that causes major disruption in several areas of life for many women. Many treatment options have been proposed, but which are most effective? A comprehensive review of the evidence, including specific treatment guidelines, is presented in the September Journal of Psychiatric Practice, published by Wolters Kluwer. [More]
FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy. [More]
Women's contraceptive choices often driven by relationships, sexual activity

Women's contraceptive choices often driven by relationships, sexual activity

Women's contraceptive choices are more often driven by current relationships and sexual activity than by long-term pregnancy intentions, according to Penn State College of Medicine researchers. [More]
Abortions performed with Mifepristone result in shorter waiting time, earlier abortions

Abortions performed with Mifepristone result in shorter waiting time, earlier abortions

Nearly all abortions in Norway today are performed with the abortion pill Mifepristone. This has resulted in shorter waiting time, earlier abortions, and the possibility to have abortions at home. [More]
Out-of-pocket expenses for oral contraceptive pills, IUD decrease since the ACA took effect: Study

Out-of-pocket expenses for oral contraceptive pills, IUD decrease since the ACA took effect: Study

Average out-of-pocket spending for oral contraceptive pills and the intrauterine device (IUD), the two most common forms of contraception for women, has decreased significantly since the Affordable Care Act (ACA) took effect. [More]
Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

More than 5,500 sociologists will convene in Chicago this August to explore ideas and scientific research relating to sexuality and many other topics, as part of the American Sociological Association's 110th Annual Meeting. This year's theme, "Sexualities in the Social World," shows the importance of research by sociologists in illuminating how social norms and social inequalities affect what sexual behavior is acceptable and who partners with whom. [More]
Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

In a first for HIV prevention, an international team of researchers have completed follow-up of participants enrolled in a pivotal Phase III trial that tested the safety and effectiveness of a vaginal ring for preventing HIV in women. [More]
Caya contoured diaphragm to expand U.S. women's options for nonhormonal barrier contraception

Caya contoured diaphragm to expand U.S. women's options for nonhormonal barrier contraception

With the launch of the Caya contoured diaphragm this June, women in the United States will have access to a method of contraception that is nonhormonal, has few side effects, and can be used for up to two years. Last fall, the United States Food and Drug Administration cleared the single-size Caya contoured diaphragm for marketing in the US, and now the diaphragm is available by prescription from healthcare providers. [More]
Advertisement
Advertisement